References
1. Villanueva G, Marceniuk G, Murphy MS, Walshaw M, Cosulich R, Guideline C. Diagnosis and management of cystic fibrosis: summary of NICE guidance. Bmj. 2017;359:j4574.
2. Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC, et al. The future of cystic fibrosis care: a global perspective. The Lancet Respiratory medicine. 2020;8(1):65-124.
3. Castellani C, Duff AJA, Bell SC, Heijerman HGM, Munck A, Ratjen F, et al. ECFS best practice guidelines: the 2018 revision. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. 2018;17(2):153-78.
4. Konstan MW, VanDevanter DR, Sawicki GS, Pasta DJ, Foreman AJ, Neiman EA, et al. Association of High-Dose Ibuprofen Use, Lung Function Decline, and Long-Term Survival in Children with Cystic Fibrosis. Annals of the American Thoracic Society. 2018;15(4):485-93.
5. McCrory BE, Harper HN, McPhail GL. Use and Incidence of Adverse Effects of Proton Pump Inhibitors in Patients with Cystic Fibrosis. Pharmacotherapy. 2018.
6. Dogru D, Cakir E, Sismanlar T, Cobanoglu N, Pekcan S, Cinel G, et al. Cystic fibrosis in Turkey: First data from the national registry. Pediatric pulmonology. 2020;55(2):541-8.
7. Roehmel JF, Schwarz C, Mehl A, Stock P, Staab D. Hypersensitivity to antibiotics in patients with cystic fibrosis. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. 2014;13(2):205-11.
8. Pleasants RA, Walker TR, Samuelson WM. Allergic reactions to parenteral beta-lactam antibiotics in patients with cystic fibrosis. Chest. 1994;106(4):1124-8.
9. Koch C, Hjelt K, Pedersen SS, Jensen ET, Jensen T, Lanng S, et al. Retrospective clinical study of hypersensitivity reactions to aztreonam and six other beta-lactam antibiotics in cystic fibrosis patients receiving multiple treatment courses. Reviews of infectious diseases. 1991;13 Suppl 7:S608-11.
10. Caimmi S, Sanfiorenzo C, Caimmi D, Bousquet PJ, Chiron R, Demoly P. Comprehensive allergy work-up is mandatory in cystic fibrosis patients who report a history suggestive of drug allergy to beta-lactam antibiotics. Clinical and translational allergy. 2012;2(1):10.
11. Matar R, Le Bourgeois M, Scheinmann P, de Blic J, Ponvert C. Beta-lactam hypersensitivity in children with cystic fibrosis: a study in a specialized pediatric center for cystic fibrosis and drug allergy. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology. 2014;25(1):88-93.
12. Braun C, Reix P, Durieu I, Nove-Josserand R, Durupt S, Ohlmann C, et al. The diagnosis of hypersensitivity to antibiotics is rarely confirmed by allergy work-up in cystic fibrosis patients. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology. 2020;31(4):396-404.
13. Demoly P, Adkinson NF, Brockow K, Castells M, Chiriac AM, Greenberger PA, et al. International Consensus on drug allergy. Allergy. 2014;69(4):420-37.
14. Romano A, Atanaskovic-Markovic M, Barbaud A, Bircher AJ, Brockow K, Caubet JC, et al. Towards a more precise diagnosis of hypersensitivity to beta-lactams - an EAACI position paper. Allergy. 2020;75(6):1300-15.
15. Brockow K, Garvey LH, Aberer W, Atanaskovic-Markovic M, Barbaud A, Bilo MB, et al. Skin test concentrations for systemically administered drugs – an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy. 2013;68(6):702-12.
16. Cavkaytar O, Karaatmaca B, Yilmaz EA, Sekerel BE, Soyer O. Testing for clarithromycin hypersensitivity: A diagnostic challenge in childhood. The journal of allergy and clinical immunology In practice. 2016;4(2):330-2 e1.
17. Aberer W, Bircher A, Romano A, Blanca M, Campi P, Fernandez J, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy. 2003;58(9):854-63.
18. Kuyucu S, Mori F, Atanaskovic-Markovic M, Caubet JC, Terreehorst I, Gomes E, et al. Hypersensitivity reactions to non-betalactam antibiotics in children: an extensive review. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology. 2014;25(6):534-43.
19. Rebelo Gomes E, Fonseca J, Araujo L, Demoly P. Drug allergy claims in children: from self-reporting to confirmed diagnosis. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 2008;38(1):191-8.
20. Erkocoglu M, Kaya A, Civelek E, Ozcan C, Cakir B, Akan A, et al. Prevalence of confirmed immediate type drug hypersensitivity reactions among school children. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology. 2013;24(2):160-7.
21. Wills R, Henry RL, Francis JL. Antibiotic hypersensitivity reactions in cystic fibrosis. Journal of paediatrics and child health. 1998;34(4):325-9.
22. Burrows JA, Nissen LM, Kirkpatrick CM, Bell SC. Beta-lactam allergy in adults with cystic fibrosis. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. 2007;6(4):297-303.
23. Macy E, Poon KYT. Self-reported antibiotic allergy incidence and prevalence: age and sex effects. The American journal of medicine. 2009;122(8):778 e1-7.
24. Orhan F, Karakas T, Cakir M, Akkol N, Bahat E, Sonmez FM, et al. Parental-reported drug allergy in 6- to 9-yr-old urban schoolchildren. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology. 2008;19(1):82-5.
25. Lange L, Koningsbruggen SV, Rietschel E. Questionnaire-based survey of lifetime-prevalence and character of allergic drug reactions in German children. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology. 2008;19(7):634-8.
26. Elsheikh A, Castrejon L, Lavergne SN, Whitaker P, Monshi M, Callan H, et al. Enhanced antigenicity leads to altered immunogenicity in sulfamethoxazole-hypersensitive patients with cystic fibrosis. The Journal of allergy and clinical immunology. 2011;127(6):1543-51 e3.
27. Tugcu GD, Cavkaytar O, Sekerel BE, Sackesen C, Kalayci O, Tuncer A, et al. Actual drug allergy during childhood: Five years’ experience at a tertiary referral centre. Allergologia et immunopathologia. 2015;43(6):571-8.
28. Greenberger PA. Drug allergy. Allergy and asthma proceedings. 2019;40(6):474-9.